|
Video: What is a Stock Split?
|
|
Luminex develops, manufactures and sells biological testing technologies and products with applications in the life sciences industries, including diagnostics, pharmaceutical and research. Co. delivers its products to various market segments, including multiplexing, reduction of labor and ability to test for proteins and nucleic acids. Co.'s products include: instruments, which include Luminex® 100/200, FLEXMAP® 3D, MAGPIX®, ARIES®, and ARIES® M1; consumables, which include MicroPlex® Microspheres, MagPlex® Microspheres, and xTAG® Microspheres; software, which includes xPONENT®, TDAS®, SYNCT, and IDEAS®; and clinical diagnostic assay product families, which include ARIES® Cassettes. According to our LMNX split history records, LMNX has had 0 splits. | |
|
LMNX (LMNX) has 0 splits in our LMNX split history database.
Looking at the LMNX split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into LMNX shares, starting with a $10,000 purchase of LMNX, presented on a split-history-adjusted basis factoring in the complete LMNX split history.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
07/14/2021 |
|
Start price/share: |
$15.90 |
|
End price/share: |
$36.99 |
|
Starting shares: |
628.93 |
|
Ending shares: |
664.37 |
|
Dividends reinvested/share: |
$1.35 |
|
Total return: |
145.75% |
|
Average Annual Total Return: |
13.27% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$24,576.32 |
|
Years: |
7.22 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
07/14/2021 |
|
Start price/share: |
$15.90 |
|
End price/share: |
$36.99 |
|
Dividends collected/share: |
$1.35 |
|
Total return: |
141.13% |
|
Average Annual Total Return: |
12.97% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$24,110.44 |
|
Years: |
7.22 |
|
|
|
|
|